Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cell-mediated tumor protection

Cancer Research

Volumn 62, Issue 18, 2002, Pages 5260-5266

  Miller, George ^a   Lahrs, Svenja ^a   Pillarisetty, Venu G ^a   Shah, Alaap B ^a   DeMatteo, Ronald P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GAMMA INTERFERON; INTERLEUKIN 12; OVALBUMIN; TUMOR ANTIGEN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOLYSIS; DENDRITIC CELL; GENE THERAPY; IMMUNOLOGICAL MEMORY; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY; VIRUS INFECTION;

ADENOVIRIDAE; ANIMALS; ANTIGENS, NEOPLASM; CHEMOTAXIS; COCULTURE TECHNIQUES; DENDRITIC CELLS; IMMUNOTHERAPY, ADOPTIVE; INTERFERON TYPE II; INTERLEUKIN-12; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOMA; MALE; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES;

EID: 0037105694     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Dendritic cells and the control of immunity
2. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis
3. Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells
4. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses
5. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids
6. Vaccination of melanoma patients with pep
7. Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors
8. Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses
9. Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas
10. Murine dendritic cells infected with adenovirus vectors show signs of activation
11. Recombinant adenovirus induces maturation of dendritic cells via an NF-κB-dependent pathway
12. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
13. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow
14. Immunologic barriers to hepatic adenoviral gene therapy for transplantation
15. The SCID but not the RAG-2 gene product is required for S μ-S epsilon heavy chain class switching
16. Establishment of an IL-12-responsive T cell clone: Its characterization and utilization in the quantitation of IL-12 activity
17. Characterization of anti-mouse IL-12 monoclonal antibodies and measurement of mouse IL-12 by ELISA
18. A new simplified single-filter assay for 'in vitro' evaluation of chemotaxis of 51Cr-labeled polymorphonuclear leukocytes
19. T cell receptor α-chain pairing determines the specificity of residue 262 within the Kb-restricted, ovalbumin257-264 determinant
20. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products
21. IL-12 increases CD80 expression and the stimulatory capacity of bone marrow-derived dendritic cells
22. Mechanisms of IFN-γ induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2
23. Dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can initiate antigen-specific humoral immunity independent of CD4+ T cells
24. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity
25. Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells
26. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells
27. Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector
28. Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset
29. Enhanced dendritic cell maturation by TNF-α or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo
30. IL-4 and CD40 ligation affect differently the differentiation, maturation, and function of human CD34+ cell-derived CD1a+
31. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: Evidence for a soluble CD14-dependent pathway
32. Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo
33. Mechanism of NK cell activation induced by coculture with dendritic cells derived from peripheral blood monocytes